Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATPase-coupled inorganic anion transmembrane transporter activity	ABCC1 ABCC4 CFTR	7.59e-05	10	175	3	GO:0043225
GeneOntologyMolecularFunction	polysaccharide binding	CLEC18A CLEC18B CLEC18C PPP1R3A	1.49e-04	31	175	4	GO:0030247
Domain	Ank	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD19P ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	2.27e-08	228	170	14	PF00023
Domain	ANK	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD19P ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	7.56e-08	251	170	14	SM00248
Domain	ANK_REPEAT	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD19P ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	8.34e-08	253	170	14	PS50088
Domain	ANK_REP_REGION	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD19P ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	8.76e-08	254	170	14	PS50297
Domain	Ank_2	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	8.80e-08	215	170	13	PF12796
Domain	Ankyrin_rpt	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD19P ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	1.28e-07	262	170	14	IPR002110
Domain	-	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	4.57e-07	248	170	13	1.25.40.20
Domain	Ankyrin_rpt-contain_dom	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	6.00e-07	254	170	13	IPR020683
Domain	MAM_1	PTPRU PTPRT EGFL6 PTPRM	1.11e-05	16	170	4	PS00740
Domain	-	CFAP251 BBS2 NBEA DENND3 MAPK8IP3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 PLXNA1 FBXW7	1.18e-05	333	170	13	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	CFAP251 BBS2 NBEA DENND3 MAPK8IP3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 PLXNA1 FBXW7	1.25e-05	335	170	13	IPR015943
Domain	MAM	PTPRU PTPRT EGFL6 PTPRM	1.44e-05	17	170	4	SM00137
Domain	MAM	PTPRU PTPRT EGFL6 PTPRM	1.84e-05	18	170	4	PF00629
Domain	MAM_dom	PTPRU PTPRT EGFL6 PTPRM	1.84e-05	18	170	4	IPR000998
Domain	MAM_2	PTPRU PTPRT EGFL6 PTPRM	1.84e-05	18	170	4	PS50060
Domain	CFTR/ABCC7	ABCC4 CFTR	8.24e-05	2	170	2	IPR009147
Domain	WD40_repeat_dom	CFAP251 BBS2 NBEA DENND3 MAPK8IP3 WDR3 LLGL1 NBEAL2 WDR17 TBL2 FBXW7	9.00e-05	297	170	11	IPR017986
Domain	WD40	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	1.35e-04	259	170	10	PF00400
Domain	WD40	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	1.78e-04	268	170	10	SM00320
Domain	WD40_repeat	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	2.00e-04	272	170	10	IPR001680
Domain	WD_REPEATS_1	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	2.38e-04	278	170	10	PS00678
Domain	WD_REPEATS_2	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	2.45e-04	279	170	10	PS50082
Domain	WD_REPEATS_REGION	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	2.45e-04	279	170	10	PS50294
Domain	TIL_dom	LRP2 MUC5AC OTOG	2.51e-04	14	170	3	IPR002919
Domain	ARM-type_fold	DOCK1 ARMC7 CAND2 ATR NBEA NCDN FOCAD DNAAF5 PIK3C2A AOPEP NBEAL2	2.84e-04	339	170	11	IPR016024
Domain	PTPc	PTPRU PTPRT PTPRM PTPRN	3.11e-04	36	170	4	SM00194
Domain	uDENN	DENND2B DENND3 MADD	3.11e-04	15	170	3	PF03456
Domain	CAP	CLEC18A CLEC18B CLEC18C	3.11e-04	15	170	3	PF00188
Domain	SCP	CLEC18A CLEC18B CLEC18C	3.11e-04	15	170	3	SM00198
Domain	Allrgn_V5/Tpx1	CLEC18A CLEC18B CLEC18C	3.11e-04	15	170	3	IPR001283
Domain	-	CLEC18A CLEC18B CLEC18C	3.11e-04	15	170	3	3.40.33.10
Domain	CAP_domain	CLEC18A CLEC18B CLEC18C	3.11e-04	15	170	3	IPR014044
Domain	DENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	SM00799
Domain	DENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	PF02141
Domain	dDENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	PF03455
Domain	UDENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	PS50946
Domain	DDENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	PS50947
Domain	dDENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	SM00801
Domain	dDENN_dom	DENND2B DENND3 MADD	3.80e-04	16	170	3	IPR005112
Domain	uDENN_dom	DENND2B DENND3 MADD	3.80e-04	16	170	3	IPR005113
Domain	DENN	DENND2B DENND3 MADD	3.80e-04	16	170	3	PS50211
Domain	DENN_dom	DENND2B DENND3 MADD	3.80e-04	16	170	3	IPR001194
Domain	TYR_PHOSPHATASE_PTP	PTPRU PTPRT PTPRM PTPRN	4.25e-04	39	170	4	PS50055
Domain	PTPase_domain	PTPRU PTPRT PTPRM PTPRN	5.16e-04	41	170	4	IPR000242
Domain	Y_phosphatase	PTPRU PTPRT PTPRM PTPRN	5.16e-04	41	170	4	PF00102
Domain	Apc4_WD40_dom	WDR3 WRAP73 WDR17	7.54e-04	20	170	3	IPR024977
Domain	ANAPC4_WD40	WDR3 WRAP73 WDR17	7.54e-04	20	170	3	PF12894
Domain	DUF4704	NBEA NBEAL2	8.09e-04	5	170	2	IPR031570
Domain	DUF4704	NBEA NBEAL2	8.09e-04	5	170	2	PF15787
Domain	TYR_PHOSPHATASE_1	DUSP9 PTPRU PTPRT PTPRM PTPRN	1.13e-03	86	170	5	PS00383
Domain	TYR_PHOSPHATASE_dom	DUSP9 PTPRU PTPRT PTPRM PTPRN	1.19e-03	87	170	5	IPR000387
Domain	TYR_PHOSPHATASE_2	DUSP9 PTPRU PTPRT PTPRM PTPRN	1.19e-03	87	170	5	PS50056
Domain	PH_BEACH	NBEA NBEAL2	1.21e-03	6	170	2	PF14844
Domain	PAK_BD	PAK2 PAK3	1.21e-03	6	170	2	IPR033923
Domain	ABC_membrane	ABCC1 ABCC4 CFTR	1.30e-03	24	170	3	PF00664
Domain	EGF_3	CLEC18A CLEC18B CLEC18C EGFL6 FBLN1 OIT3 LRP2 OTOG	1.42e-03	235	170	8	PS50026
Domain	-	DUSP9 PTPRU PTPRT PTPRM PTPRN	1.53e-03	92	170	5	3.90.190.10
Domain	HISTONE_H3_1	H3C1 H3-3A	1.68e-03	7	170	2	PS00322
Domain	Pept_C14A_CASP1-typ	CASP7 CASP9	1.68e-03	7	170	2	IPR017350
Domain	PTPc_motif	PTPRU PTPRT PTPRM PTPRN	2.04e-03	59	170	4	SM00404
Domain	Tyr_Pase_cat	PTPRU PTPRT PTPRM PTPRN	2.04e-03	59	170	4	IPR003595
Domain	EGF-like_dom	CLEC18A CLEC18B CLEC18C EGFL6 FBLN1 OIT3 LRP2 OTOG	2.05e-03	249	170	8	IPR000742
Domain	ABC_TM1F	ABCC1 ABCC4 CFTR	2.05e-03	28	170	3	PS50929
Domain	ABC1_TM_dom	ABCC1 ABCC4 CFTR	2.05e-03	28	170	3	IPR011527
Domain	DEATH-like_dom	CASP9 DAPK1 NLRP3 MADD NOD2	2.12e-03	99	170	5	IPR011029
Domain	Prot-tyrosine_phosphatase-like	DUSP9 PTPRU PTPRT PTPRM PTPRN	2.12e-03	99	170	5	IPR029021
Domain	HISTONE_H3_2	H3C1 H3-3A	2.22e-03	8	170	2	PS00959
Domain	Histone_H3/CENP-A	H3C1 H3-3A	2.22e-03	8	170	2	IPR000164
Domain	PH-BEACH_dom	NBEA NBEAL2	2.22e-03	8	170	2	IPR023362
Domain	H3	H3C1 H3-3A	2.22e-03	8	170	2	SM00428
Domain	-	NBEA NBEAL2	2.22e-03	8	170	2	2.30.29.40
Domain	PH_BEACH	NBEA NBEAL2	2.22e-03	8	170	2	PS51783
Domain	EGF_1	CLEC18A CLEC18B CLEC18C ITGB7 EGFL6 FBLN1 OIT3 LRP2	2.37e-03	255	170	8	PS00022
Domain	BEACH	NBEA NBEAL2	2.84e-03	9	170	2	PS50197
Domain	Beach	NBEA NBEAL2	2.84e-03	9	170	2	PF02138
Domain	-	NBEA NBEAL2	2.84e-03	9	170	2	1.10.1540.10
Domain	Beach	NBEA NBEAL2	2.84e-03	9	170	2	SM01026
Domain	BEACH_dom	NBEA NBEAL2	2.84e-03	9	170	2	IPR000409
Domain	EGF_2	CLEC18A CLEC18B CLEC18C ITGB7 EGFL6 FBLN1 OIT3 LRP2	3.01e-03	265	170	8	PS01186
Domain	WD40_repeat_CS	DENND3 WDR3 LLGL1 WDR17 TBL2 FBXW7	3.93e-03	164	170	6	IPR019775
Domain	CASPASE_HIS	CASP7 CASP9	4.29e-03	11	170	2	PS01121
Domain	Tyr_Pase_AS	PTPRU PTPRT PTPRM PTPRN	4.43e-03	73	170	4	IPR016130
Domain	-	PAK2 PAK3	5.12e-03	12	170	2	3.90.810.10
Domain	Caspase_his_AS	CASP7 CASP9	5.12e-03	12	170	2	IPR016129
Domain	CASPASE_CYS	CASP7 CASP9	5.12e-03	12	170	2	PS01122
Domain	Pept_C14_p10	CASP7 CASP9	5.12e-03	12	170	2	IPR002138
Domain	C8	MUC5AC OTOG	5.12e-03	12	170	2	PF08742
Domain	TIL	MUC5AC OTOG	5.12e-03	12	170	2	PF01826
Domain	Caspase_cys_AS	CASP7 CASP9	5.12e-03	12	170	2	IPR033139
Domain	CASPASE_P10	CASP7 CASP9	5.12e-03	12	170	2	PS50207
Domain	DUF4599	SPATA31D4 SPATA31D3	5.12e-03	12	170	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	5.12e-03	12	170	2	IPR027970
Domain	EGF	CLEC18A CLEC18B CLEC18C EGFL6 FBLN1 OIT3 LRP2	5.81e-03	235	170	7	SM00181
Domain	CASc	CASP7 CASP9	6.01e-03	13	170	2	SM00115
Domain	Unchr_dom_Cys-rich	MUC5AC OTOG	6.01e-03	13	170	2	IPR014853
Domain	Pept_C14A	CASP7 CASP9	6.01e-03	13	170	2	IPR015917
Domain	C8	MUC5AC OTOG	6.01e-03	13	170	2	SM00832
Domain	ABC_transporter_CS	ABCC1 ABCC4 CFTR	6.56e-03	42	170	3	IPR017871
Domain	-	CASP7 CASP9	6.98e-03	14	170	2	3.40.50.1460
Domain	Pept_C14_p20	CASP7 CASP9	6.98e-03	14	170	2	IPR001309
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	4.67e-08	8	179	4	12634303
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18A CLEC18B CLEC18C	1.34e-07	3	179	3	26170455
Pubmed	Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms.	CASP7 CASP9 PAK2	1.34e-07	3	179	3	27889207
Pubmed	The C-type lectin-like domain superfamily.	CLEC18A CLEC18B CLEC18C	1.34e-07	3	179	3	16336259
Pubmed	Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.	CLEC18A CLEC18B CLEC18C	1.34e-07	3	179	3	33603190
Pubmed	Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.	H3-7 H3C15 H3C1 H3-3A	2.18e-07	11	179	4	15471871
Pubmed	Human PAD4 regulates histone arginine methylation levels via demethylimination.	PADI4 H3-7 H3C15 H3-3A	2.18e-07	11	179	4	15345777
Pubmed	The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.	CLEC18A CLEC18B CLEC18C	5.34e-07	4	179	3	16709836
Pubmed	Expression patterns and post-translational modifications associated with mammalian histone H3 variants.	H3-7 H3C15 H3C1 H3-3A	6.52e-07	14	179	4	16267050
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 MYCBP2 OBSCN IPP MLLT10 ELAC2 CASZ1 MADD MAPK8IP3 NOD2 FOCAD SLC6A8 C2CD3 SSU72 NBEAL2 PCYT2 TANC1 ATP2A3 MED12 PLXNA1	1.22e-06	1105	179	20	35748872
Pubmed	Human spleen histone H3. Isolation and amino acid sequence.	H3-7 H3C15 H3-3A	1.33e-06	5	179	3	7309716
Pubmed	Modifications of human histone H3 variants during mitosis.	H3-7 H3C15 H3-3A	1.33e-06	5	179	3	16185088
Pubmed	Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation.	H3-7 H3C15 H3-3A	2.65e-06	6	179	3	10464286
Pubmed	Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.	H3-7 H3C15 H3-3A	2.65e-06	6	179	3	15525939
Pubmed	Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase.	H3-7 H3C15 H3-3A	2.65e-06	6	179	3	12560483
Pubmed	The IA-2 interactome.	PTPRT MADD PTPRN	2.65e-06	6	179	3	16273344
Pubmed	Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification.	H3-7 H3C15 H3-3A	2.65e-06	6	179	3	17189264
Pubmed	Organismal differences in post-translational modifications in histones H3 and H4.	H3-7 H3C15 H3-3A	2.65e-06	6	179	3	17194708
Pubmed	Histone deimination antagonizes arginine methylation.	PADI4 H3C15 H3-3A	2.65e-06	6	179	3	15339660
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SUPT20H MYCBP2 ZNF423 TRPS1 NBEA DNAAF9 DALRD3 MADD MAPK8IP3 FOCAD PLEKHH1 WDR3 FRY AP2M1 PPP1R16B LRP2 PAK2 H3-3A TNKS WDR17 ZNF292	3.23e-06	1285	179	21	35914814
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	MEF2D CASZ1 PLEKHH1 SPATA31D4 SPATA31D3 AARS2 SCAPER ZNF292 PGBD2	3.68e-06	233	179	9	37704626
Pubmed	Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.	H3-7 H3C15 H3C1 H3-3A	3.79e-06	21	179	4	11242053
Pubmed	Phosphorylation of Ser28 in histone H3 mediated by mixed lineage kinase-like mitogen-activated protein triple kinase alpha.	H3-7 H3C15 H3-3A	4.62e-06	7	179	3	15684425
Pubmed	Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation.	H3-7 H3C15 H3-3A	4.62e-06	7	179	3	11856369
Pubmed	The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment.	H3-7 H3C15 H3-3A	4.62e-06	7	179	3	15681610
Pubmed	Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.	H3-7 H3C15 H3-3A	4.62e-06	7	179	3	16497732
Pubmed	Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	NPHP1 ZNF423 BBS2 PKHD1 BBS12	7.30e-06	52	179	5	20301743
Pubmed	Semaphorin-Mediated Corticospinal Axon Elimination Depends on the Activity-Induced Bax/Bak-Caspase Pathway.	CASP7 CASP9 PLXNA1	7.37e-06	8	179	3	32471877
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	SUPT20H NCKAP1 DUSP9 OBSCN CASP9 NBEA NBEAL2 SHPRH ATP2A3 TBL2 MED12 ZNF292	1.14e-05	497	179	12	36774506
Pubmed	PP1α, PP1β and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3.	H3C1 PAK2 H3-3A	1.57e-05	10	179	3	23828041
Pubmed	RNase L and the NLRP3-inflammasome: An old merchant in a new trade.	NLRP3 RNASEL	2.63e-05	2	179	2	26987611
Pubmed	Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma.	ABCC1 ABCC4	2.63e-05	2	179	2	24024181
Pubmed	Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease.	CFTR PKHD1	2.63e-05	2	179	2	34329764
Pubmed	Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.	NLRP3 NOD2	2.63e-05	2	179	2	28403163
Pubmed	Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines.	ABCC1 ABCC4	2.63e-05	2	179	2	33081264
Pubmed	Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.	ELAC2 RNASEL	2.63e-05	2	179	2	18767027
Pubmed	Death-associated protein kinase-mediated cell death modulated by interaction with DANGER.	DAPK1 ITPRIP	2.63e-05	2	179	2	20053891
Pubmed	H2O2 stimulates cystic fibrosis transmembrane conductance regulator through an autocrine prostaglandin pathway, using multidrug-resistant protein-4.	ABCC4 CFTR	2.63e-05	2	179	2	23742099
Pubmed	Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.	ELAC2 RNASEL	2.63e-05	2	179	2	27318894
Pubmed	Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines.	CASP7 PAK2	2.63e-05	2	179	2	21555521
Pubmed	Synergism of NOD2 and NLRP3 activators promotes a unique transcriptional profile in murine dendritic cells.	NLRP3 NOD2	2.63e-05	2	179	2	20884650
Pubmed	FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.	ABCC1 FBXW7	2.63e-05	2	179	2	25586348
Pubmed	The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice.	CFTR MUC5AC	2.63e-05	2	179	2	9843919
Pubmed	Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex.	CASP7 CASP9	2.63e-05	2	179	2	16352606
Pubmed	PLCL1 regulates fibroblast-like synoviocytes inflammation via NLRP3 inflammasomes in rheumatoid arthritis.	NLRP3 PLCL1	2.63e-05	2	179	2	35820936
Pubmed	Localization of multidrug resistance-associated proteins along the blood-testis barrier in rat, macaque, and human testis.	ABCC1 ABCC4	2.63e-05	2	179	2	24130369
Pubmed	Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins.	TANC2 TANC1	2.63e-05	2	179	2	21068316
Pubmed	Comparison of the gene expression profiles from normal and Fgfrl1 deficient mouse kidneys reveals downstream targets of Fgfrl1 signaling.	CLEC18A CLEC18B BMP2K CLEC18C	3.92e-05	37	179	4	22432025
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 CTTNBP2 NCKAP1 MYCBP2 DAPK1 NBEA KEAP1 ZBTB1 NCDN MAPK8IP3 RAD50 FRY PAK2 PAK3 TNKS PLCL1	4.19e-05	963	179	16	28671696
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	DOCK1 CTTNBP2 KEAP1 USP37 TNKS TANC1	5.51e-05	128	179	6	25332235
Pubmed	Comparative analysis of apoptosis and inflammation genes of mice and humans.	CASP7 CASP9 DAPK1 MADD NOD2	6.01e-05	80	179	5	12819136
Pubmed	An atlas of genetic influences on human blood metabolites.	ABCC1 ABCC4 CFAP251 ACADL SLC6A12 SLC17A1 SCAPER	6.12e-05	190	179	7	24816252
Pubmed	Prognostic significance of PAK family kinases in acute myeloid leukemia.	PAK2 PAK3	7.88e-05	3	179	2	30890765
Pubmed	Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).	ABCC1 ABCC4	7.88e-05	3	179	2	16156793
Pubmed	Meloxicam increases intracellular accumulation of doxorubicin via downregulation of multidrug resistance-associated protein 1 (MRP1) in A549 cells.	ABCC1 ABCC4	7.88e-05	3	179	2	26600514
Pubmed	Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line.	CASP7 CASP9	7.88e-05	3	179	2	21142842
Pubmed	Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.	PAK2 PAK3	7.88e-05	3	179	2	15182717
Pubmed	MicroRNA miR-223 modulates NLRP3 and Keap1, mitigating lipopolysaccharide-induced inflammation and oxidative stress in bovine mammary epithelial cells and murine mammary glands.	KEAP1 NLRP3	7.88e-05	3	179	2	37710276
Pubmed	Tumor suppressor death-associated protein kinase is required for full IL-1β production.	DAPK1 NLRP3	7.88e-05	3	179	2	21041719
Pubmed	Effect of cortisol on caspases in the co-cultured C2C12 and 3 T3-L1 cells.	CASP7 CASP9	7.88e-05	3	179	2	24752940
Pubmed	Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation.	TANC2 TANC1	7.88e-05	3	179	2	38092135
Pubmed	Endoplasmic reticulum stress-induced death of mouse embryonic fibroblasts requires the intrinsic pathway of apoptosis.	CASP7 CASP9	7.88e-05	3	179	2	17371867
Pubmed	Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis.	CASP7 CASP9	7.88e-05	3	179	2	23834359
Pubmed	Molecular recognition of histone H3 by the WD40 protein WDR5.	H3C15 H3C1	7.88e-05	3	179	2	16829960
Pubmed	Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex.	H3C15 H3C1	7.88e-05	3	179	2	16829959
Pubmed	Growth arrest and DNA damage 45γ is required for caspase-dependent renal tubular cell apoptosis.	CASP7 GADD45G	7.88e-05	3	179	2	30794682
Pubmed	Regulation of BMP2K in AP2M1-mediated EGFR internalization during the development of gallbladder cancer.	BMP2K AP2M1	7.88e-05	3	179	2	32792513
Pubmed	Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.	ELAC2 RNASEL	7.88e-05	3	179	2	15824169
Pubmed	Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.	ABCC1 ABCC4	7.88e-05	3	179	2	15886284
Pubmed	The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis.	NLRP3 NOD2	7.88e-05	3	179	2	31186034
Pubmed	Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells.	NLRP3 MUC5AC	7.88e-05	3	179	2	29906464
Pubmed	Nucleotide oligomerization domain-2 interacts with 2'-5'-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells.	NOD2 RNASEL	7.88e-05	3	179	2	19853919
Pubmed	Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men.	NLRP3 NOD2	7.88e-05	3	179	2	19319132
Pubmed	The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.	CASP7 CASP9	7.88e-05	3	179	2	12586738
Pubmed	Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis?	NLRP3 NOD2	7.88e-05	3	179	2	20384614
Pubmed	Characterization of efflux transport proteins of the human choroid plexus papilloma cell line HIBCPP, a functional in vitro model of the blood-cerebrospinal fluid barrier.	ABCC1 ABCC4	7.88e-05	3	179	2	25986174
Pubmed	Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation.	PAK2 PAK3	7.88e-05	3	179	2	10075701
Pubmed	The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment.	PAK2 PAK3	7.88e-05	3	179	2	23335370
Pubmed	Opposing roles of PAK2 and PAK4 in synergistic induction of MUC5AC mucin by bacterium NTHi and EGF.	PAK2 MUC5AC	7.88e-05	3	179	2	17555715
Pubmed	Group I Paks as therapeutic targets in NF2-deficient meningioma.	PAK2 PAK3	7.88e-05	3	179	2	25596744
Pubmed	Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.	ELAC2 RNASEL	7.88e-05	3	179	2	20086112
Pubmed	Cepharanthine induces apoptosis through the mitochondria/caspase pathway in murine dendritic cells.	CASP7 CASP9	7.88e-05	3	179	2	27121492
Pubmed	NOD-like receptors in the human upper airways: a potential role in nasal polyposis.	NLRP3 NOD2	7.88e-05	3	179	2	21241317
Pubmed	Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.	ELAC2 RNASEL	7.88e-05	3	179	2	15714208
Pubmed	The expression and function of Nod-like receptors in neutrophils.	NLRP3 NOD2	7.88e-05	3	179	2	20002790
Pubmed	The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties.	PAK2 PAK3	7.88e-05	3	179	2	18507705
Pubmed	DAPK1 may be a potential biomarker for arterial aneurysm in clinical treatment and activated inflammation levels in arterial aneurysm through NLRP3 inflammasome by Beclin1.	DAPK1 NLRP3	7.88e-05	3	179	2	34796763
Pubmed	Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice.	CFTR MUC5AC	7.88e-05	3	179	2	20413542
Pubmed	NLRP3 Inflammasome Assembly in Neutrophils Is Supported by PAD4 and Promotes NETosis Under Sterile Conditions.	PADI4 NLRP3	7.88e-05	3	179	2	34122445
Pubmed	Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.	CFTR NLRP3	7.88e-05	3	179	2	29021150
Pubmed	Gallium(III) complexes of α-N-heterocyclic piperidylthiosemicarbazones: Synthesis, structure-activity relationship, cellular uptake and activation of caspases-3/7/9.	CASP7 CASP9	7.88e-05	3	179	2	29842999
Pubmed	Molecular modeling in the age of clinical genomics, the enterprise of the next generation.	CFTR NOD2	7.88e-05	3	179	2	28204942
Pubmed	Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.	PAK2 PAK3	7.88e-05	3	179	2	38785043
Pubmed	ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.	ABCC1 ABCC4	7.88e-05	3	179	2	21799180
Pubmed	TPP1 Blocks an ATR-Mediated Resection Mechanism at Telomeres.	ATR ACD	7.88e-05	3	179	2	26778124
Pubmed	Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei.	CTTNBP2 CFTR	7.88e-05	3	179	2	15364959
Pubmed	The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity.	PAK2 PAK3	7.88e-05	3	179	2	11278486
Pubmed	Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes.	CASP7 CASP9	7.88e-05	3	179	2	18086147
Pubmed	Knockdown of DAPK1 inhibits IL-1β-induced inflammation and cartilage degradation in human chondrocytes by modulating the PEDF-mediated NF-κB and NLRP3 inflammasome pathway.	DAPK1 NLRP3	7.88e-05	3	179	2	36412004
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	TANC2 ABCC1 ABCC4 MARCHF6 DAPK1 PGAP4 COQ3 MADD MRPS30 LLGL1 PTPRM PAK2 ITPRIP	9.78e-05	719	179	13	35337019
Cytoband	1q44	OR2AK2 NLRP3 KIF28P ZBTB18 PGBD2	7.49e-05	110	179	5	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2AK2 NLRP3 KIF28P ZBTB18 PGBD2	1.53e-04	128	179	5	chr1q44
GeneFamily	Ankyrin repeat domain containing	TANC2 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P RNASEL ANKRD20A4P ANKRD30A PPP1R16B TNKS TANC1 ANKRD20A1 ANKRD7	2.30e-08	242	131	13	403
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRU PTPRT PTPRM PTPRN	1.43e-05	21	131	4	813
GeneFamily	WD repeat domain containing	CFAP251 NBEA DENND3 WDR3 LLGL1 NBEAL2 WRAP73 WDR17 TBL2 FBXW7	2.13e-05	262	131	10	362
GeneFamily	ATP binding cassette subfamily C	ABCC1 ABCC4 CFTR	1.01e-04	13	131	3	807
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND2B DENND3 MADD	7.61e-04	25	131	3	504
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA NBEAL2	1.81e-03	9	131	2	1230
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL6 IPP KEAP1 ZBTB1 ZBTB18	2.93e-03	134	131	5	861
GeneFamily	Kelch like\|BTB domain containing	KLHL6 IPP KEAP1	3.47e-03	42	131	3	617
GeneFamily	Caspases\|Caspase recruitment domain containing	CASP7 CASP9	3.86e-03	13	131	2	468
GeneFamily	Ring finger proteins	MARCHF6 MEX3C RNF150 PCGF6 RNF125 CHFR SHPRH	3.93e-03	275	131	7	58
GeneFamily	C-type lectin domain family	CLEC18A CLEC18B CLEC18C	4.78e-03	47	131	3	494
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	ZC3HC1 TRIP4	5.14e-03	15	131	2	26
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 ABCC1 SUPT20H ATR NCKAP1 BMP2K MYCBP2 MARCHF6 DAPK1 DENND2B JARID2 SEC24D BMPR1A C2CD3 PTPRM PIK3C2A TNKS TRAM2 ZBTB18 ZNF292	1.26e-06	856	175	20	M4500
Coexpression	GSE22033_WT_VS_PPARG_KO_MEF_UP	ATR CASP9 FBLN1 MYG1 GADD45G PPP1R16B PAK3 ANKRD7 ZNF292	6.91e-06	195	175	9	M7694
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	NCKAP1 TCIRG1 DGKH DENND3 NLRP3 BMPR1A PTPRM NBEAL2 PPP1R16B	7.81e-06	198	175	9	M6511
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	CAND2 CFTR KEAP1 MADD PPP1R16B LRP2 PLCL1 TRAM2 ATP2A3	8.13e-06	199	175	9	M8401
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	NBEA DGKH PTPRM SLC17A1 AOPEP PKHD1 LRP2 PLCL1	2.52e-05	176	175	8	M39223
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 NCKAP1 BMP2K ATP8A2 TCIRG1 TRIP4 DENND3 TC2N ITPRIP	6.43e-08	185	179	9	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC\|mLN / shred on region, Cell_type, and subtype	ABCC4 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P DENND2B SLC6A12 ANKRD20A4P ANKRD20A1	1.15e-07	198	179	9	da84c76afe835aeee39da04b63c03549218b5d91
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|mLN / Region, Cell class and subclass	ABCC4 CTTNBP2 DAPK1 ANKRD20A2P ANKRD20A3P DENND2B SLC6A12 ANKRD20A4P ANKRD20A1	1.15e-07	198	179	9	3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TANC2 NBEA DGKH CASZ1 PLEKHH1 TC2N TANC1 MUC5AC	6.71e-07	179	179	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 ABCC4 CTTNBP2 ATP8A2 OBSCN DENND2B GADD45G PTPRM	9.71e-07	188	179	8	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	OBSCN USP37 MAPK8IP3 RNF150 AOPEP TANC1 PLCL1 FBXW7	1.05e-06	190	179	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TANC2 ATP8A2 DAPK1 PTPRT FRY GADD45G PAK3 ATP2A3	1.09e-06	191	179	8	54f07e4de61735051498846afb44b1798bed8144
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	KLHL6 TRPS1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1	1.14e-06	192	179	8	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DNAAF9 PTPRM SLC17A1 AOPEP SCAPER PKHD1 LRP2 PLCL1	1.14e-06	192	179	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DAPK1 NBEA CHKA CASZ1 GALNT13 TANC1 GALNT6 ATP2A3	1.54e-06	200	179	8	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ABCC4 CFTR OBSCN CHKA RNF150 TC2N GALNT6 PHTF1	1.54e-06	200	179	8	be83f442179ba4217d12f0458059586ff3130991
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 CFTR PTPRT GALNT13 PKHD1 LRP2 WDR17	3.92e-06	160	179	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 CFTR PTPRT GALNT13 PKHD1 LRP2 WDR17	3.92e-06	160	179	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	DOCK1 COL6A3 TRPS1 GADD45G PTPRM PIK3C2A BBS12	7.89e-06	178	179	7	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHP1 NCKAP1 ALS2 ZBTB1 CASZ1 FBLN1 PLXNA1	8.80e-06	181	179	7	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	Control-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PPP1R16B PAK3 ANKRD20A1	9.80e-06	184	179	7	c6affa0b12510363258f65e46bf2d47bf4a8e75f
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1 FBXW7	9.80e-06	184	179	7	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCC4 CFTR CHKA GALNT13 SEC24D TC2N	9.80e-06	184	179	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	Control-Myeloid-cDC1\|Control / Disease state, Lineage and Cell class	KLHL6 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1	1.05e-05	186	179	7	b05c394aa3573ba855abc3066739ca193883b0c3
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL6 NXPE4 PLEKHH1 FRY PTPRM PPP1R16B ATP2A3	1.09e-05	187	179	7	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL6 NXPE4 PLEKHH1 FRY PTPRM PPP1R16B ATP2A3	1.09e-05	187	179	7	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCC4 CFTR CHKA GALNT13 SEC24D TC2N	1.13e-05	188	179	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1 LRP2	1.13e-05	188	179	7	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1 LRP2	1.17e-05	189	179	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	OBSCN MAPK8IP3 RNF150 AOPEP TANC1 PLCL1 FBXW7	1.17e-05	189	179	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFTR DAPK1 CHKA FRY TC2N PTPRM PKHD1	1.21e-05	190	179	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	COPD-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	ABCC4 CTTNBP2 NCKAP1 BMP2K CFTR TANC1 ATP2A3	1.21e-05	190	179	7	379dbac19110b76079a7a53209569e060a852acb
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC4 NXPE4 TMEM255B NOD2 RNF125 PTPRM PPP1R16B	1.21e-05	190	179	7	2655df8c0883dd811fa7617301f9c4b0a4dd55ec
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	ABCC1 TRPS1 DGKH ZC3H7A PAK2 PLCL1 ZNF292	1.25e-05	191	179	7	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 ABCC4 CTTNBP2 DAPK1 DGKH SLC6A12 PKHD1	1.25e-05	191	179	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1 LRP2	1.25e-05	191	179	7	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL FRY LRRIQ1 TC2N PKHD1 LRP2 MUC5AC	1.29e-05	192	179	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 ABCC4 DAPK1 DGKH AOPEP PKHD1 FBXL2	1.38e-05	194	179	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1 LRP2	1.38e-05	194	179	7	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1 LRP2	1.38e-05	194	179	7	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TANC2 BBS2 DGKH CASZ1 TC2N OR2A25 ZNF292	1.52e-05	197	179	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 TRPS1 NBEA FOCAD SCAPER TNKS FBXW7	1.63e-05	199	179	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	ABCC1 NCDN PTPRT SHC2 PTPRM TMPRSS7 TRAM2	1.68e-05	200	179	7	a6500d0d2e8bcac92381ab771dbdee66b0e1d48e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	CFTR OBSCN CHKA RNF150 TC2N CLUH PHTF1	1.68e-05	200	179	7	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	(53)_Lymphoid_DC\|World / shred on Cell_type and subtype	ABCC4 BMP2K DAPK1 ANKRD20A2P ANKRD20A3P DENND2B ANKRD20A1	2.16e-05	208	179	7	30212cfacad94a7cc562a69efa73a31259851515
ToppCell	TCGA-Kidney\|World / Sample_Type by Project: Shred V9	CLEC18A CLEC18B SLC6A12 SLC17A1 PKHD1 LRP2	3.37e-05	151	179	6	e31974c0d0a0c644205a0ee6013ab74a09d8a306
ToppCell	COVID-19-Mast_cells-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	ABCC4 CTTNBP2 BMP2K ALS2 NBEA PLCL1	4.04e-05	156	179	6	bc10b94673184ef384c6665b16a1209a8975a4f1
ToppCell	COVID-19-Mast_cells\|COVID-19 / group, cell type (main and fine annotations)	ABCC4 CTTNBP2 BMP2K ALS2 NBEA PLCL1	4.04e-05	156	179	6	159504d43421ee83b9ab484816333ae549c9c2fd
ToppCell	T_cells-TFH-like_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	COL6A3 TRPS1 DGKH GADD45G PTPRM BBS12	5.34e-05	164	179	6	b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BMP2K DAPK1 DGKH MADD EGFL6 PCYT2	5.52e-05	165	179	6	94a5211072464fc24592bb107a853ce832e816fe
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCC4 CTTNBP2 BMP2K ALS2 NBEA PLCL1	5.52e-05	165	179	6	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCC4 CTTNBP2 BMP2K ALS2 NBEA PLCL1	5.52e-05	165	179	6	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCC4 CTTNBP2 BMP2K ALS2 NBEA PLCL1	5.52e-05	165	179	6	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP7 ALS2 DENND3 MADD PLEKHH1 TNKS	5.91e-05	167	179	6	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TCIRG1 SEC24D TRAM2 ATP2A3 FBXW7	5.91e-05	167	179	6	0130743084dbcb20e10f96715d30961122150cbf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TCIRG1 SEC24D TRAM2 ATP2A3 FBXW7	5.91e-05	167	179	6	7bcae3797d3a0811e7f39885afdfd29ec517f11b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TCIRG1 SEC24D TRAM2 ATP2A3 FBXW7	5.91e-05	167	179	6	c6f0209a1ad797631fdfa3efab6db6b1d3e8e315
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	CTTNBP2 BMP2K ATP8A2 ALS2 NBEA PLCL1	6.31e-05	169	179	6	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DGKH DENND2B SLC6A12 PAK3 PLCL1 WDR17	6.52e-05	170	179	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	CTTNBP2 BMP2K ATP8A2 ALS2 NBEA PLCL1	6.52e-05	170	179	6	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALS2 USP37 NCDN BBS12 TBL2 FBXW7	7.18e-05	173	179	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALS2 USP37 NCDN BBS12 TBL2 FBXW7	7.18e-05	173	179	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC4 CAND2 PTPRT PIK3C2A ATP2A3 TBL2	7.41e-05	174	179	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	COVID-19-lung-MAST\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KLHL6 ABCC4 CTTNBP2 BMP2K ALS2 PLCL1	7.90e-05	176	179	6	473c45a381ca109207d66ed1635668b391ea0e1f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1CF TDRD9 GALNT13 HHATL PAK3 GPR119	8.15e-05	177	179	6	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1CF TDRD9 GALNT13 HHATL PAK3 GPR119	8.15e-05	177	179	6	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	(5)_Glands_mucous\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	NXPE4 NBEA GALNT13 GALNT6 ATP2A3 MUC5AC	8.40e-05	178	179	6	f0f19b0d78f2cc5df4d4c321a953a6e447d5114a
ToppCell	Mid-temporal_gyrus_(MTG)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RNF150 SHC2 SCAPER PKHD1 PLXNA1 SYCE1	8.40e-05	178	179	6	ad187db4c40b9078d54dd915c143e0172b2f47b8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 CTTNBP2 ACADL DAPK1 PTPRT PKHD1	8.40e-05	178	179	6	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCC4 CHKA GALNT13 SEC24D TC2N	8.67e-05	179	179	6	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	(5)_Epithelial_cells-(5)_Glands_mucous\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	NXPE4 NBEA GALNT13 GALNT6 ATP2A3 MUC5AC	8.94e-05	180	179	6	a4118adaf4b09e2ca01b662ed60e7bbf32a24d58
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLEC18A ISLR2 CFTR ALS2 NBEA AARS2	8.94e-05	180	179	6	12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLEC18A ISLR2 CFTR ALS2 NBEA AARS2	8.94e-05	180	179	6	1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLEC18A ISLR2 CFTR ALS2 NBEA AARS2	8.94e-05	180	179	6	2a28fbfe10a340c8662c2c8be33792f41fc09088
ToppCell	droplet-Lung-nan-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR GALNT13 EGFL6 OIT3 LRP2 TBL2	9.49e-05	182	179	6	cfba75c1ffc39ac76db9e8e27394731942882b30
ToppCell	droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR GALNT13 EGFL6 OIT3 LRP2 TBL2	9.49e-05	182	179	6	d836bfdc298ecd3558a973e393a329eb8bd59d79
ToppCell	droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR GALNT13 EGFL6 OIT3 LRP2 TBL2	9.49e-05	182	179	6	7e7c7a26460d3003cdf0c0ffb96208a566aa09a7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR OBSCN GALNT13 PKHD1 LRP2 OTOG	1.01e-04	184	179	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFTR DAPK1 CHKA EGFL6 TC2N LRP2	1.01e-04	184	179	6	49705c8fec565b16216bdf48e83e27521f52d99a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR OBSCN GALNT13 PKHD1 LRP2 OTOG	1.01e-04	184	179	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4\|TCGA-Uvea / Sample_Type by Project: Shred V9	DENND3 SEC24D RNF125 GADD45G PIK3C2A PHTF1	1.01e-04	184	179	6	9c56753e5e668be888662e4713cf4ce44e6c58fb
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	KLHL6 TANC2 RTF2 RAD50 ANKRD20A4P PIK3C2A	1.01e-04	184	179	6	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR OBSCN GALNT13 PKHD1 LRP2 OTOG	1.01e-04	184	179	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCC4 CHKA GALNT13 TC2N GADD45G	1.01e-04	184	179	6	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	ABCC1 TRPS1 DGKH ZC3H7A PLCL1 ZNF292	1.04e-04	185	179	6	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1	1.07e-04	186	179	6	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ACADL FRY LRRIQ1 TC2N PKHD1 LRP2	1.07e-04	186	179	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCC4 CHKA GALNT13 SEC24D TC2N	1.07e-04	186	179	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	CF\|World / Disease state, Lineage and Cell class	PADI4 DENND3 NLRP3 JARID2 ITPRIP ZNF292	1.10e-04	187	179	6	eec4d4e4a658e3a61c05745167a1a5e3d39bb43e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 DAPK1 DGKH LRRIQ1 PKHD1 FBXL2	1.10e-04	187	179	6	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ACADL PPP1R3A LRRIQ1 TC2N PKHD1 LRP2	1.10e-04	187	179	6	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 DAPK1 DGKH LRRIQ1 PKHD1 FBXL2	1.10e-04	187	179	6	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 DAPK1 DGKH LRRIQ1 PKHD1 FBXL2	1.10e-04	187	179	6	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCC1 CASZ1 NOD2 JARID2 PIK3C2A PPP1R16B	1.10e-04	187	179	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1	1.13e-04	188	179	6	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC4 NXPE4 TMEM255B RNF125 PTPRM PPP1R16B	1.13e-04	188	179	6	20072a2a3f9ecbe727c850629f19420cf60e4bc5
ToppCell	facs-Trachea-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC4 NXPE4 TMEM255B RNF125 PTPRM PPP1R16B	1.13e-04	188	179	6	dd817059e1b4225e84733559f7839cc973b7dfd6
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ACADL CFTR FRY LRRIQ1 TC2N PKHD1	1.13e-04	188	179	6	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC4 NXPE4 TMEM255B RNF125 PTPRM PPP1R16B	1.13e-04	188	179	6	6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P PAK3 ANKRD20A1	1.13e-04	188	179	6	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TANC2 CFTR DAPK1 EGFL6 TC2N LRP2	1.13e-04	188	179	6	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCC1 ABCC4 CTTNBP2 BMP2K ALS2 GALNT6	1.17e-04	189	179	6	f01158bb15df3117fae1271bf8cf8c2501422671
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFTR DAPK1 CHKA EGFL6 TC2N LRP2	1.20e-04	190	179	6	8ff8c586237cf15f930416710bcff45205fe6f70
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ACADL FRY LRRIQ1 TC2N PKHD1 LRP2	1.20e-04	190	179	6	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 OBSCN PCDHA11 DGKH DENND2B EGFL6	1.20e-04	190	179	6	4eb92aef1ee868f4537483d19014d947b7684612
Disease	Intellectual Disability	TANC2 ATP8A2 NBEA MAPK8IP3 SLC6A8 FRY AP2M1 RNF125 SCAPER LRP2 PCYT2 ZNF292	9.39e-06	447	166	12	C3714756
Disease	Colorectal Carcinoma	ABCC1 ABCC4 CFTR OBSCN IPP PTPRU NCDN PTPRT BMPR1A PUS10 PKHD1 LRP2 FBXL2 ZNF292 FBXW7	1.11e-05	702	166	15	C0009402
Disease	Ciliopathies	NPHP1 ZNF423 CFTR BBS2 PKHD1 BBS12	3.83e-05	110	166	6	C4277690
Disease	cortical surface area measurement	SCFD2 TANC2 CTTNBP2 MYCBP2 ATP8A2 ZNF423 DAPK1 DNAAF9 ELAC2 DENND3 FOCAD PCGF6 ANKRD19P LRRIQ1 GADD45G AOPEP PKHD1 TNKS PLCL1 ZBTB18	7.26e-05	1345	166	20	EFO_0010736
Disease	intestinal disease (is_implicated_in)	NOD2 BMPR1A	9.40e-05	3	166	2	DOID:5295 (is_implicated_in)
Disease	ureteral obstruction (biomarker_via_orthology)	CASP7 CASP9 KEAP1 PAK2	1.20e-04	45	166	4	DOID:5199 (biomarker_via_orthology)
Disease	Acne Vulgaris	NLRP3 NOD2	1.87e-04	4	166	2	C0001144
Disease	4-hydroxyphenylpyruvate measurement	CFAP251 SLC17A1	1.87e-04	4	166	2	EFO_0800120
Disease	Acne	NLRP3 NOD2	1.87e-04	4	166	2	C0702166
Disease	response to radiation, pain	ABCC4 EGFL6	1.87e-04	4	166	2	EFO_0003843, GO_0009314
Disease	Pyoderma Gangrenosum	NLRP3 NOD2	1.87e-04	4	166	2	C0085652
Disease	Prostatic Neoplasms	ABCC4 ATR CASP9 KEAP1 ELAC2 CASZ1 FBLN1 GUCD1 RNASEL LRP2 MED12 ZNF292	2.03e-04	616	166	12	C0033578
Disease	Malignant neoplasm of prostate	ABCC4 ATR CASP9 KEAP1 ELAC2 CASZ1 FBLN1 GUCD1 RNASEL LRP2 MED12 ZNF292	2.03e-04	616	166	12	C0376358
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	MMS22L TRPS1 MLLT10 PPP1R3A GADD45G PKHD1 TNKS TRAM2 SLC37A4	2.32e-04	364	166	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Choledochal Cyst, Type I	CFTR PKHD1	3.11e-04	5	166	2	C0009439
Disease	Choledochal Cyst, Type II	CFTR PKHD1	3.11e-04	5	166	2	C1257796
Disease	Choledochal Cyst, Type III	CFTR PKHD1	3.11e-04	5	166	2	C1257797
Disease	Choledochal Cyst, Type IV	CFTR PKHD1	3.11e-04	5	166	2	C1257798
Disease	Choledochal Cyst, Type V	CFTR PKHD1	3.11e-04	5	166	2	C1257799
Disease	endometritis (biomarker_via_orthology)	CASP7 CASP9	3.11e-04	5	166	2	DOID:1002 (biomarker_via_orthology)
Disease	Choledochal Cyst	CFTR PKHD1	3.11e-04	5	166	2	C0008340
Disease	Abnormal muscle tone	MAPK8IP3 ZNF292	4.65e-04	6	166	2	C0852413
Disease	GLIOMA SUSCEPTIBILITY 1	H3C1 H3-3A	4.65e-04	6	166	2	C2750850
Disease	Hidradenitis Suppurativa	NLRP3 NOD2	6.49e-04	7	166	2	C0162836
Disease	presubiculum volume	ZNF423 TRPS1 PLCL1	7.00e-04	31	166	3	EFO_0009400
Disease	disease recurrence, malaria	PTPRT PTPRM	8.61e-04	8	166	2	EFO_0001068, EFO_0004952
Disease	Global developmental delay	NBEA MAPK8IP3 AP2M1 PCYT2 ZBTB18	9.55e-04	133	166	5	C0557874
Disease	neuroimaging measurement	SCFD2 CLEC18A CTTNBP2 TRPS1 DUSP9 IPP MLLT10 ELAC2 DENND3 MAPK8IP3 LRRIQ1 GADD45G PKHD1 PLCL1 TBL2	1.08e-03	1069	166	15	EFO_0004346
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 CFTR	1.10e-03	9	166	2	DOID:1485 (implicated_via_orthology)
Disease	pulmonary sarcoidosis (is_implicated_in)	CFTR NOD2	1.10e-03	9	166	2	DOID:13406 (is_implicated_in)
Disease	Autosomal Recessive Polycystic Kidney Disease	CFTR PKHD1	1.10e-03	9	166	2	C0085548
Disease	Abnormality of nervous system morphology	MAPK8IP3 ZNF292	1.37e-03	10	166	2	C4022810
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CFTR PKHD1	1.67e-03	11	166	2	DOID:0110861 (biomarker_via_orthology)
Disease	Bardet-Biedl syndrome (implicated_via_orthology)	BBS2 SCAPER	1.67e-03	11	166	2	DOID:1935 (implicated_via_orthology)
Disease	body fat percentage	MMS22L TRPS1 MLLT10 PPP1R3A GADD45G PKHD1 TNKS TRAM2 SLC37A4	1.85e-03	488	166	9	EFO_0007800
Disease	Paroxysmal atrial fibrillation	CAND2 CASZ1 MEX3C AOPEP PAK2	1.93e-03	156	166	5	C0235480
Disease	familial atrial fibrillation	CAND2 CASZ1 MEX3C AOPEP PAK2	1.93e-03	156	166	5	C3468561
Disease	Persistent atrial fibrillation	CAND2 CASZ1 MEX3C AOPEP PAK2	1.93e-03	156	166	5	C2585653
Disease	serum albumin measurement	TRPS1 TCIRG1 MLLT10 CHKA NLRP3 MADD FRY LLGL1 SSU72 SLC37A4	2.00e-03	592	166	10	EFO_0004535
Disease	body weight	DOCK1 MMS22L ZNF423 TRPS1 DUSP9 BBS2 DGKH MLLT10 PTPRT MEX3C PPP1R3A H3C1 PTPRN CHFR PLCL1 PLXNA1	2.08e-03	1261	166	16	EFO_0004338
Disease	neutrophil count	SCFD2 MYCBP2 ZNF423 PCDHA11 ZC3HC1 DGKH DENND2B MEF2D CASZ1 NLRP3 EGFL6 ZC3H7A NBEAL2 PAK2 PLCL1 PHTF1 ZNF292	2.10e-03	1382	166	17	EFO_0004833
Disease	Atrial Fibrillation	CAND2 CASZ1 MEX3C AOPEP PAK2	2.16e-03	160	166	5	C0004238
Disease	liver cirrhosis (implicated_via_orthology)	RAD50 FOCAD	2.36e-03	13	166	2	DOID:5082 (implicated_via_orthology)
Disease	developmental disorder of mental health (implicated_via_orthology)	TANC2 NCKAP1 TANC1	2.66e-03	49	166	3	DOID:0060037 (implicated_via_orthology)
Disease	gastric ulcer (implicated_via_orthology)	CFTR MUC5AC	2.74e-03	14	166	2	DOID:10808 (implicated_via_orthology)
Disease	membranous glomerulonephritis (biomarker_via_orthology)	PTPRU LRP2	2.74e-03	14	166	2	DOID:10976 (biomarker_via_orthology)
Disease	Bardet-Biedl syndrome (is_implicated_in)	NPHP1 BBS2	2.74e-03	14	166	2	DOID:1935 (is_implicated_in)
Disease	sodium measurement	MMS22L MLLT10 PKHD1 PLCL1	2.77e-03	103	166	4	EFO_0009282
Disease	Peripheral Nervous System Diseases	ABCC1 CASP9 DAPK1	3.51e-03	54	166	3	C4721453
Disease	filaggrin gene expression measurement	TRPS1 RNF150	3.58e-03	16	166	2	EFO_0020899
Disease	grip strength measurement	MMS22L TRPS1 MLLT10 PPP1R3A JARID2 GADD45G PLCL1	3.79e-03	350	166	7	EFO_0006941
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS2 BBS12	4.05e-03	17	166	2	C2936862
Disease	cyclic adenosine monophosphate measurement	ABCC4 PTPRM	4.05e-03	17	166	2	EFO_0010473
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	AP2M1 ZNF292	4.05e-03	17	166	2	DOID:0060307 (is_implicated_in)
Disease	Drug habituation	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0013170
Disease	Drug abuse	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0013146
Disease	Prescription Drug Abuse	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C4316881
Disease	Substance-Related Disorders	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0236969
Disease	Drug Use Disorders	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0013222
Disease	Drug Dependence	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C1510472
Disease	Substance Dependence	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0038580
Disease	Substance Use Disorders	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	DOCK1 ABCC4 CFTR TMPRSS7	4.12e-03	115	166	4	C0029231
Disease	blood urea nitrogen measurement	DUSP9 DAPK1 DGKH CASZ1 MRPS30 PKHD1 LRP2 TANC1	4.20e-03	452	166	8	EFO_0004741
Disease	cortical thickness	CTTNBP2 MYCBP2 ZNF423 TRPS1 ZC3HC1 DNAAF9 MLLT10 ELAC2 DENND3 MAPK8IP3 LRRIQ1 GADD45G PKHD1 CLUH	4.24e-03	1113	166	14	EFO_0004840
Disease	Substance abuse problem	DOCK1 ABCC4 CFTR TMPRSS7	4.24e-03	116	166	4	C0740858
Disease	glucose homeostasis measurement, acute insulin response measurement	PTPRM ATP2A3	4.54e-03	18	166	2	EFO_0006831, EFO_0006896
Disease	Malignant neoplasm of endometrium	ATR FBXW7	4.54e-03	18	166	2	C0007103
Disease	Bardet-Biedl syndrome	BBS2 BBS12	4.54e-03	18	166	2	cv:C0752166
Disease	Carcinoma in situ of endometrium	ATR FBXW7	4.54e-03	18	166	2	C0346191
Disease	Phenyllactate (PLA) measurement	DAPK1 SLC17A1	5.05e-03	19	166	2	EFO_0021662
Disease	superior temporal gyrus volume measurement	CTTNBP2 ANKRD7	5.05e-03	19	166	2	EFO_0010331
Disease	chronic obstructive pulmonary disease (is_implicated_in)	ABCC1 CFTR NOD2	5.42e-03	63	166	3	DOID:3083 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QAVHCQEEACAVILL	ANKRD20A1	106	Q5TYW2
IVECLAEHGADLNAC	DAPK1	526	P53355
LNISVDCSFNHGICD	EGFL6	396	Q8IUX8
QAVHCQEEACAVILL	ANKRD20A8P	106	Q5CZ79
AFADCTVILCEHRIE	CFTR	1391	P13569
LLGVCASVDNCRLFV	A1CF	126	Q9NQ94
ICVTRAFVDNCLQLH	ACADL	341	P28330
VACGAFHSLALVQCL	ALS2	206	Q96Q42
FHCVVEECGALFSTL	CASZ1	1031	Q86V15
QAVHCQEEACAVILL	ANKRD20A4P	106	Q4UJ75
EHVIDLETFLQCCCQ	COQ3	226	Q9NZJ6
QAVHCQEEACAVILL	ANKRD20A5P	106	A0PJZ0
CHQEACANILIDSGA	ANKRD30A	116	Q9BXX3
ICAGFLIHAIDSNSC	ACOT12	491	Q8WYK0
CQEEECATILLEHGA	ANKRD26P1	126	Q6NSI1
NHGSEDFLLVLDCCD	AOPEP	136	Q8N6M6
HVDFECLFTCLSVRQ	DENND2B	871	P78524
CVHFLVLTDVCGNRT	DENND3	61	A2RUS2
LQIFCDTCEAVARLH	BMP2K	156	Q9NSY1
AVEFLCLSCLHILAE	BBS12	541	Q6ZW61
QFDGLVELATICALC	ATP2A3	406	Q93084
CIQEFLTLLAVCHTV	ATP8A2	496	Q9NTI2
CQEEACAIILLEHGA	ANKRD19P	111	Q9H560
QGHANIISCLCVSED	CFAP251	296	Q8TBY9
VCLALAGEACHVQVV	ISLR2	566	Q6UXK2
ALAETFCLNCGIIAL	RAD50	1216	Q92878
EVVHLCCEFLKGQID	IPP	121	Q9Y573
EGACHLSCLQIASFL	ITPRIP	401	Q8IWB1
TCLACLTNLGDVHVF	LLGL1	876	Q15334
QAVHCQEEACAVILL	ANKRD20A2P	106	Q5SQ80
FCASNIIDHFICDIS	OR6C70	166	A6NIJ9
HAVCVLGTLTQLDIC	PADI4	16	Q9UM07
CGQSAECSIHLEVIV	PCDHA11	96	Q9Y5I1
AVCRECLQALDFLHS	PAK3	381	O75914
HQIFCDLVPVLSLAC	OR6K3	191	Q8NGY3
CLLITDVALEHLENC	FBXL2	351	Q9UKC9
LCSHLEVCIQDGLFG	PTPRN	46	Q16849
HFFCEVPALLSLVCQ	OR2AK2	191	Q8NG84
LCVDIQEFSCHRVVL	KLHL6	76	Q8WZ60
LFGVVNTVACLDHLD	HHATL	306	Q9HCP6
VDACLQVLTCILLEH	MADD	306	Q8WXG6
VVDQFTVCNAHVLCI	MAPK8IP3	796	Q9UPT6
IGLQTCCHIFLNLVV	NCDN	516	Q9UBB6
NISLFEEHCETLLCD	MMS22L	251	Q6ZRQ5
LVGLFEDTNLCAIHA	H3-3A	101	P84243
NGTFHCDEALACALL	MYG1	51	Q9HB07
LVGLFEDTNLCAIHA	H3-7	101	Q5TEC6
NCDFCVHGNDITLTV	PCYT2	106	Q99447
CTHNVADCAFLEGRV	PLXNA1	686	Q9UIW2
VFLHCRVLVCGVLDE	OIT3	491	Q8WWZ8
ALSTCGSHICVILLF	OR52B6	256	Q8NGF0
VAECDLVCTFFHPLL	PIK3C2A	1521	O00443
FLITGIVQVACQECH	GPR119	241	Q8TDV5
IDEALSQNCGVLVHC	DUSP9	276	Q99956
TENLLADCLQGCFVV	MARCHF6	136	O60337
CSHECNQRLVVLFGV	MED12	746	Q93074
GHNICVNLSVVCDGI	LRP2	1321	P98164
CEELLHGQLFSGCVA	MUC5AC	266	P98088
GQDVICSHTEGLICL	MUC5AC	2011	P98088
IAIDDCTFHQCVRLS	AP2M1	241	Q96CW1
ETLVEFAIGGLCNLC	ARMC7	71	Q9H6L4
CEGHQLFLCNVERSV	PGAP4	136	Q9BRR3
LVGLFEDTNLCAIHA	H3C1	101	P68431
VVGNCGLICLISHEE	OR52N2	41	Q8NGI0
ICDAATIHCLLEQEL	DGKH	1006	Q86XP1
LHGLDGCTNIQCLEL	LRRIQ1	876	Q96JM4
HVCELLNTIDVCQVF	NCKAP1	106	Q9Y2A7
LIVELHTLCDCNCSD	ITGB7	466	P26010
VHDAILEACLCGNTA	PTPRT	1136	O14522
FIHDAILEACLCGET	PTPRU	1136	Q92729
QETVCCELSSLADHG	PPP1R3A	706	Q16821
GQVITFLDAHCECTL	GALNT13	201	Q8IUC8
HSLRQDGAVCELQIC	OBSCN	3406	Q5VST9
DAEVSRHLFELCICQ	ABCC4	566	O15439
SRNEIEHCLCSNLGV	OR56B4	176	Q8NH76
GLTALHQCCIDNFEE	PPP1R16B	101	Q96T49
IDECVTGIHNCSINE	FBLN1	526	P23142
AAVCRECLQALEFLH	PAK2	346	Q13177
CAVLEIECAHGAVFV	PUS10	276	Q3MIT2
CVVVSFLCLLLIHNE	SLC37A4	176	O43826
AIVLVNSGVLHCDLC	GUCD1	146	Q96NT3
QAVHCQEEACAVILL	ANKRD20A3P	106	Q5VUR7
LTGECVHVDFNCLFN	ATR	2486	Q13535
TLTCIICQDLLHDCV	CHFR	301	Q96EP1
GHIQLICCSVDGEIR	BBS2	301	Q9BXC9
LVTQHCSGEACFLAE	C2CD3	1271	Q4AC94
DLEACCQLLSHILEV	DOCK1	876	Q14185
LCAAAAQGHFECVEL	CTTNBP2	781	Q8WZ74
VFCHNDCQEGNILLL	CHKA	301	P35790
QAEVLTFLDAHCECF	GALNT6	261	Q8NCL4
IHFTLIQAFCCENDI	GADD45G	76	O95257
QQDHGALDCCVVVIL	CASP9	221	P55211
ALDCCVVVILSHGCQ	CASP9	226	P55211
DFLENVLTCHVCLDI	COL6A3	2576	P12111
LKGHDDHVITCLQFC	FBXW7	376	Q969H0
DHVITCLQFCGNRIV	FBXW7	381	Q969H0
CITNGHCFAIIEEDD	BMPR1A	76	P36894
SELCAFLVTLHKECG	DNAAF9	761	Q5TEA3
ACANGHTDVVLFLIE	ANKRD7	66	Q92527
CFACILLSHGEENVI	CASP7	136	P55210
DLNVRCESEVFHACI	KEAP1	236	Q14145
GCLVVHVVSCEEEFQ	DALRD3	276	Q5D0E6
LACQDLRVHQLGCEV	FRY	1191	Q5TBA9
VQALVSVCHEDCGVA	DNAAF5	501	Q86Y56
SVCHEDCGVASLQLL	DNAAF5	506	Q86Y56
CLGQLDICEFLNHVE	CAND2	1101	O75155
VSCESLLHEVIVCVG	SCAPER	1261	Q9BY12
NCDGLEEAVLHTCIA	KIF28P	661	B7ZC32
CCEGLVALVAQDHAE	FOCAD	66	Q5VW36
QGLHALCQAEVVCIR	FOCAD	631	Q5VW36
SEAGIFCLVNHVSFC	NPHP1	256	O15259
SVLCDCEIALIIFNH	MEF2D	36	Q14814
FIHDAILEACLCGDT	PTPRM	1146	P28827
FLSHLAVVDIACACS	OR2A25	61	A4D2G3
ACQVDIICGDHLLEQ	PCGF6	301	Q9BYE7
ENVVFCLECALRHVE	JARID2	1156	Q92833
AEQDCVRHICLEGQL	OTOG	2056	Q6ZRI0
CGNNVIDHITCEILA	OR13D1	201	Q8NGV5
IPLCGNLIDHFTCEI	OR2K2	166	Q8NGT1
VRLECVGNCIVLFAA	ABCC1	1201	P33527
FCFVHLLCLDFTVAE	RNF150	21	Q9ULK6
ELICIAEHCTNLTAL	FBXL21P	356	Q9UKT6
GLSHECCFDISLVLS	NLRP3	781	Q96P20
ALRAVACDCLLQEHF	MRPS30	141	Q9NP92
VCHTCGAAFQEDDVI	RTF2	156	Q9BY42
CHAELELGTCFQAVN	TC2N	351	Q8N9U0
CCAIVDGVFAAQHIE	TMEM255B	101	Q8WV15
IVLGHVFGCLDECLI	TDRD9	611	Q8NDG6
HSECGLILNTNAELC	NXPE4	216	Q6UWF7
HLDVVTCLALDTCGI	NBEAL2	2501	Q6ZNJ1
HEVVCVSVCAELGLV	NBEA	2781	Q8NFP9
LVGLFEDTNLCAIHA	H3C15	101	Q71DI3
GLSFLVHCCNVIITA	SLC17A1	21	Q14916
HDCVICFENEVIAAL	MEX3C	606	Q5U5Q3
LGLDSQFVCVECLVT	SLC6A12	391	P48065
HRGHLFVCVTLCEQT	RNASEL	426	Q05823
CEEAHRQLVCALNGL	SHPRH	1016	Q149N8
CLVPEFVHSIAALLC	TANC1	516	Q9C0D5
CLVPEFVHNVAALLC	TANC2	466	Q9HCD6
HCLDIDLNFICLSGL	SPATA31D4	21	Q6ZUB0
FDCELRAVQVSCGFH	MYCBP2	936	O75592
VLAACCHLAIDNIEL	WDR17	961	Q8IZU2
DHFCLCFLETEAVVG	WRAP73	436	Q9P2S5
CVILSLGDHTILCQV	PKHD1	1431	P08F94
CVEIFRHEDCANASL	SLC6A8	181	P48029
LCEHLGVREECFAVG	SCFD2	226	Q8WU76
ALQTSVELCCGTHLL	AARS2	741	Q5JTZ9
LAKDCVAHGCSVTLF	SEC24D	621	O94855
LAHSVEVCSFLQECG	SPTBN5	996	Q9NRC6
HQGALVCLAESCLTL	ACD	181	Q96AP0
FHVTCAQFAGLLCEE	MLLT10	166	P55197
HLCSAGQAAIEAFVC	CLEC18A	166	A5D8T8
HLCSAGQTAIEAFVC	CLEC18B	166	Q6UXF7
HLCSAGQAAIEAFVC	CLEC18C	166	Q8NCF0
LCCLRQELVDAFVEH	CLUH	601	O75153
LHRICCQDAQVDLLA	PGBD2	501	Q6P3X8
DIQVHVTACILSVCG	ZC3HC1	241	Q86WB0
ADQICEDCAFSILHG	PLCL1	181	Q15111
DELSTKCVHCGIVFL	TRPS1	1211	Q9UHF7
HCLDIDLNFICLSGL	SPATA31D3	21	P0C874
PVTSFDCAVCLEVLH	RNF125	31	Q96EQ8
TCDLEEFQTCLVRHC	ELAC2	631	Q9BQ52
CLEENHLQDEGVCSL	NOD2	961	Q9HC29
LSIAFICCAQVLQGH	PHTF1	621	Q9UMS5
ACHILECCEGLAQSI	SHC2	276	P98077
AKGHIFCEDCVAAIL	TMPRSS7	186	Q7RTY8
LEDVKHQLCSLCGAE	SYCE1	206	Q8N0S2
NHADIGFCLVLCVLI	TRAM2	21	Q15035
ACSFGHAEVVSLLLC	TNKS	256	O95271
EQRHQGFLCDCTVLV	ZBTB18	16	Q99592
SQVNIFHCGCVIAEI	SUPT20H	131	Q8NEM7
CELHFLATLAQETGV	ZNF292	146	O60281
DLEHCLQGSVKICDA	PLEKHH1	1051	Q9ULM0
HLSAGETICQVCFQI	ZBTB1	656	Q9Y2K1
LEGTHELRQACQICF	ZC3H7A	436	Q8IWR0
LTGLHSVADIFCESC	YPEL4	76	Q96NS1
LASHHIGECCFQEIE	ZNF888	76	P0CJ79
FEVQHSIICKACGEI	USP37	481	Q86T82
DSVIQECVQFLGHCE	TTC30A	606	Q86WT1
LFCGTLVCTHEEQDI	TRIP4	201	Q15650
CGETFSTEVELQCHI	ZNF423	786	Q2M1K9
CHGTDSVLELFCILS	WDR3	296	Q9UNX4
GAFLICELCQCIQHT	SSU72	151	Q9NP77
ECFERVHGECIANLS	TBL2	366	Q9Y4P3
QAIHTIEFCLGCVSN	TCIRG1	716	Q13488